Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: For relief of the signs and symptoms of osteoarthritis US FDA label
Kidney dosing: Diclofenac (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- Usual dose by indication: osteoarthritis 100 to 150 mg/day, rheumatoid arthritis 150 to 200 mg/day, in divided doses (label). Lowest effective dose, shortest duration.
- CrCl 30–59 mL/min
- No dose change (pharmacokinetics unchanged; label). Kidney impairment raises the risk of NSAID kidney injury: monitor creatinine, potassium and blood pressure; avoid volume depletion and the ACE inhibitor or ARB plus diuretic combination.
- CrCl 15–29 mL/min
- No information from controlled studies in advanced kidney disease; avoid unless benefits outweigh the risk of worsening kidney function, and if used monitor kidney function (label, Renal Toxicity). Pharmacokinetics are unchanged in kidney impairment (inulin clearance down to <30 mL/min), so the risk is kidney injury, not accumulation.
- CrCl <15 mL/min (not on dialysis)
- No information from controlled studies in advanced kidney disease; avoid unless benefits outweigh the risk of worsening kidney function, and if used monitor kidney function (label, Renal Toxicity). Pharmacokinetics are unchanged in kidney impairment (inulin clearance down to <30 mL/min), so the risk is kidney injury, not accumulation.
- Hemodialysis (intermittent)
- Avoid unless benefits outweigh the risk (advanced kidney disease; label). Not removed by dialysis (over 99% protein-bound). NSAIDs may hasten loss of residual kidney function.
- Peritoneal dialysis
- Avoid unless benefits outweigh the risk (label). NSAIDs may hasten loss of residual kidney function.
- CRRT
- Avoid: NSAIDs can worsen acute kidney injury.
- Dialyzable? Unlikely: hemodialysis may not be useful because of high protein binding (over 99%; label).
- Monitoring Creatinine, potassium and blood pressure in CKD, heart failure, liver disease, dehydration or with ACE inhibitors, ARBs or diuretics. Liver enzymes within 4 to 8 weeks of starting long-term use (diclofenac hepatotoxicity warning).
From the Diclofenac monograph (renalcarematters.com, reviewed).
- levomenthol no separate page
- linum usitatissimum seed no separate page
Use: Uses For the temporary relief of minor aches and pains of muscles and joints associated with: simple backache arthritis strains bruises sprains US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Topical gel: 0.369 g (1.16 % w/w)/3.150 g (10 % w/w)/1.575 g (5 % w/w)/0.318 g (1 % w/w) per 30 g, 0.369 g/3.150 g/1.575 g/0.318 g (1.16 %/10 %/5 %/1 % w/w) per 30 g
Registered products in the Philippines
2 products registered with the Food and Drug Administration (FDA) Philippines list Diclofenac + Levomenthol + Linum usitatissimum seed + Methyl salicylate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
DiclometDiclofenac (as diethylamine) + Methyl Salicylate + Levomenthol +Linum usitatissimum (Linseed) Seed | 0.369g (1.16% w/w) / 3.150g (10% w/w) / 1.575g (5% w/w) / 0.318g (1% w/w) per 30g Topical Gel30 g in Lami Tube (Box of 1's) | Rx | S Kant Healthcare Ltd.India | Biocare Lifesciences, Inc. | DRP-12520 | Aug 26, 2027 | |
Dition-PlusDiclofenac (as Diethylamine) + Methyl Salicylate + Levomenthol + Linum usitatissimum (Linseed) Seed | 0.369g / 3.150 g / 1.575 g / 0.318g (1.16% / 10% / 5% / 1% w/w) per 30g Topical GelLaminated Tube with Peel-off Seal x 30g (Box of 1’s) | Rx | S Kant Healthcare LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-11475 | Mar 15, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .